Harrison Seth Loring Insider Trades

Insider Trading History

Track insider trading activity for Harrison Seth Loring. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Stoke Therapeutics
Stoke Therapeutics STOK
Director
Holding Value $553k 17,786 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$524k 17,786 shares
$29.46
$31.11
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $0 0 shares
Last Trade
Dec 09, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$6.42M 117,398 shares
$54.65
$54.65
Stoke Therapeutics
Stoke Therapeutics STOK
Director
Holding Value $925k 29,747 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$324k 29,747 shares
$10.90
$31.11
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $7.96M 145,699 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$485k 9,398 shares
$51.61
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $1.42M 26,000 shares
Last Trade
Jun 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$599k 26,000 shares
$23.02
$54.65
Stoke Therapeutics
Stoke Therapeutics STOK
Director
Holding Value $238k 7,639 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$125k 7,639 shares
$16.41
$31.11
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $820k 15,000 shares
Last Trade
Jun 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$762k 15,000 shares
$50.83
$54.65
Stoke Therapeutics
Stoke Therapeutics STOK
Director
Holding Value $605k 19,441 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$242k 19,441 shares
$12.46
$31.11
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $8.37M 153,242 shares
Last Trade
Nov 30, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.09M 23,131 shares
$46.94
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $8.8M 160,962 shares
Last Trade
Oct 28, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.78M 44,103 shares
$40.31
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $11.5M 210,790 shares
Last Trade
Oct 27, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.76M 138,598 shares
$41.54
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $15.7M 287,852 shares
Last Trade
Oct 26, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.01M 137,468 shares
$43.75
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $17.9M 326,813 shares
Last Trade
Oct 25, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$423k 9,421 shares
$44.92
$54.65
Stoke Therapeutics
Stoke Therapeutics STOK
Director
Holding Value $653k 21,000 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$272k 21,000 shares
$12.96
$31.11
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $820k 15,000 shares
Last Trade
Jun 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$122k 15,000 shares
$8.13
$54.65
Stoke Therapeutics
Stoke Therapeutics STOK
10% owner
Holding Value $362k 11,650 shares
Last Trade
Jun 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$470k 11,650 shares
$40.37
$31.11
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $710k 13,000 shares
Last Trade
Jun 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$342k 13,000 shares
$26.32
$54.65
Stoke Therapeutics
Stoke Therapeutics STOK
10% owner
Holding Value $534M 17,161,713 shares
Last Trade
Nov 24, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17.7M 375,000 shares
$47.33
$31.11
Akero Therapeutics
Akero Therapeutics AKRO
10% owner
Holding Value $319M 5,830,203 shares
Last Trade
Jul 10, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.9M 415,000 shares
$36.00
$54.65
Stoke Therapeutics
Stoke Therapeutics STOK
10% owner
Holding Value $460k 14,777 shares
Last Trade
Jun 03, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$392k 14,777 shares
$26.53
$31.11

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up